| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |